Takeda is enlisting data integration player Koneksa Health on a scheme to bring new digital health tools to its clinical trials. The partnership will see Takeda using Koneksa’s remote data collection capabilities in trials for multiple pipeline candidates.
The goal of the tie-up is to develop “digital biomarkers” that could support decision-making and eventually contribute to new endpoints that will improve the assessment of patients in their natural environment, according to a statement.
The Japanese pharma will use Koneksa’s platform to integrate biosensors and wearables in a number of early-stage clinical trials, according to the statement. The technology facilitates the collection of patient-generated data that were previously tricky to obtain, such as patients’ continuous vital signs, activity levels and sleep metrics, Takeda said.
No comments:
Post a Comment